查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
人類微生物組市場規模 - 按部位（消化道、肺）、應用（治療、診斷）、疾病（傳染病、胃腸道疾病）、產品（藥物、診斷測試、益生菌）和全球預測 2023-2032
市場調查報告書
商品編碼
1368684

人類微生物組市場規模 - 按部位（消化道、肺）、應用（治療、診斷）、疾病（傳染病、胃腸道疾病）、產品（藥物、診斷測試、益生菌）和全球預測 2023-2032

Human Microbiome Market Size - By Site (Digestive Tract, Lung), Application (Therapeutics, Diagnostics), Disease (Infectious Diseases, Gastrointestinal Diseases), Product (Drugs, Diagnostic Tests, Probiotics) & Global Forecast 2023-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

在全球優先考慮該領域研究的資助計劃和政府計劃不斷增加的推動下，2023 年至 2032 年間，全球人類微生物組市場佔有率將以 25.4% 的年複合成長率成長。微生物組研究的財政支持可加速科學進步，從而促進創新療法和診斷工具的開發。

2022 年7 月，杜蒙特-加州大學洛杉磯分校移植中心獲得了總計1150 萬美元的聯邦政府撥款，用於支持研究工作，其目標是延長捐贈器官的生存能力並提高移植受者的整體健康狀況和壽命。這些贈款一筆由美國國立衛生研究院提供，另一筆由國防部提供，致力於提高肝臟移植以及手部和臉部移植的效果。這些投資吸引了製藥和生物技術公司，促進了合作並擴大了市場。強調了解微生物組在健康和疾病中的作用，使人類微生物組產業在未來幾年顯著成長。

整個人類微生物組市場根據地點、應用、疾病、產品和地區進行分類。

到 2032 年，診斷領域可能會以可觀的成長率擴張。人們日益認知到微生物組在健康和疾病中發揮的重要作用，從而推動了對人類微生物組診斷的需求。研究人員和醫療保健專業人員越來越認知到，個別微生物組的組成可以為各種健康狀況提供有價值的見解，包括胃腸道疾病、自體免疫疾病，甚至心理健康問題。因此，人們對基於微生物組的診斷越來越感興趣，從而產生了對先進測試和分析方法的需求。

到 2032 年，益生菌細分市場可能會佔據一定的人類微生物組產業佔有率。人類微生物組益生菌由於其支持腸道健康和整體福祉的潛力而需求量很大。這些益生菌含有有益微生物，可以幫助維持腸道微生物組的平衡，而腸道微生物組與從消化到免疫功能等健康的各個方面越來越相關。尋求自然方法來改善健康的消費者正在轉向微生物益生菌，這為這些產品創造了強勁的市場需求。

由於多種因素，亞太地區人類微生物組產業正在不斷擴張。人們越來越認知到微生物組在健康中發揮的關鍵作用，這推動了對基於微生物組的產品和服務的需求。此外，慢性健康狀況的增加激發了人們對微生物組研究和治療的興趣。此外，該地區不斷增加的醫療基礎設施和研究投資進一步促進了亞太地區人類微生物組產業的成長。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：人類微生物組產業洞察

  • 產業格局
  • 產業影響力
    • 成長動力
      • 與生活方式相關的疾病負擔日益加重，老年人口不斷增加
      • 增加資助計劃和政府計劃
      • 精準醫療需求不斷成長
    • 產業陷阱與挑戰
      • 監理途徑長、開發成本高
      • 道德和安全問題
  • 成長潛力分析
  • COVID-19 影響分析
  • 監管環境
    • 美國
    • 歐洲
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 公司定位矩陣
  • 戰略儀表板

第 5 章：人類微生物組市場：依地點分類，2018 年 - 2032 年

  • 主要動向：依站點
  • 消化道
  • 肺
  • 生殖腔
  • 皮膚
  • 其他網站

第 6 章：人類微生物組市場：按應用，2018 - 2032

  • 主要動向：按應用
  • 療法
  • 診斷

第 7 章：人類微生物組市場：依疾病分類，2018 - 2032

  • 主要動向：按疾病
  • 傳染性疾病
  • 胃腸道疾病
  • 內分泌及代謝疾病
  • 癌症
  • 中樞神經系統失調
  • 其他疾病

第 8 章：人類微生物組市場：依產品分類，2018 - 2032

  • 主要動向：按產品
  • 藥品
  • 益生菌
  • 益生元
  • 診斷測試
  • 其他產品

第 9 章：人類微生物組市場：按地區分類，2018 - 2032

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • MEA
    • 南非
    • 沙烏地阿拉伯
    • MEA 的其餘部分

第 10 章：公司簡介

  • Seres Therapeutics
  • Enterome
  • Second Genome Inc.
  • DuPont
  • Synthetic Biologics, Inc.
  • Synlogic
  • Vedanta Biosciences, Inc.
  • Metabiomics Corporation
  • MICROBIOME THERAPEUTICS LLC
  • 4D pharma plc
Product Code: 6538

Global Human Microbiome Market share will grow at 25.4% CAGR between 2023 and 2032, driven by the increasing funding initiatives and government programs worldwide prioritizing research in this field. Financial support for microbiome research accelerates scientific advancements, leading to the development of innovative therapies and diagnostic tools.

In July 2022, the Dumont-UCLA Transplant Center secured a combined $11.5 million in federal government grants to support research endeavors with the goal of extending the viability of donated organs and enhancing the overall health and longevity of transplant recipients. These grants, one provided by the National Institutes of Health and the other by the Department of Defense, are dedicated to advancing the outcomes of liver transplantation and hand and face transplantation. These investments attract pharmaceutical and biotechnology companies, fostering collaborations and expanding the market. The emphasis on understanding the role of the microbiome in health and disease positions the human microbiome industry for significant growth in the coming years.

The overall human microbiome market is segregated based on site, application, disease, product, and region.

The diagnostics segment could expand at a decent growth rate through 2032. The demand for human microbiome diagnostics is propelled by the growing awareness of the significant role the microbiome plays in health and disease. Researchers and healthcare professionals are increasingly recognizing that the composition of an individual's microbiome can provide valuable insights into various health conditions, including gastrointestinal disorders, autoimmune diseases, and even mental health issues. As a result, there's a rising interest in microbiome-based diagnostics, creating a demand for advanced testing and analysis methods.

The probiotics segment could capture a modest human microbiome industry share by 2032. Human microbiome probiotics are in high demand due to their potential to support gut health and overall well-being. These probiotics contain beneficial microorganisms that can help maintain a balanced gut microbiome, which is increasingly linked to various aspects of health, from digestion to immune function. Consumers seeking natural ways to improve their health are turning to microbiome probiotics, creating a strong market demand for these products.

Asia Pacific human microbiome industry is expanding due to several factors. A growing awareness of the pivotal role the microbiome plays in health is driving demand for microbiome-based products and services. Besides, the rise in chronic health conditions has spurred interest in microbiome research and therapies. Moreover, the region's increasing healthcare infrastructure and research investments further facilitate the growth of the human microbiome industry in the Asia Pacific.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Global human microbiome industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Site trends
    • 2.1.4 Application trends
    • 2.1.5 Disease trends
    • 2.1.6 Product trends

Chapter 3 Human Microbiome Industry Insights

  • 3.1 Industry landscape
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing burden of lifestyle-related diseases and the growing geriatric population
      • 3.2.1.2 Increasing funding initiatives and government program
      • 3.2.1.3 Increasing demand precision medicine
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Long regulatory pathways and high development costs
      • 3.2.2.2 Ethical and safety concern
  • 3.3 Growth potential analysis
    • 3.3.1 By site
    • 3.3.2 By application
    • 3.3.3 By disease
    • 3.3.4 By product
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players
  • 4.4 Company positioning matrix
  • 4.5 Strategy dashboard, 2022

Chapter 5 Human Microbiome Market, By Site, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by site
  • 5.2 Digestive tract
  • 5.3 Lung
  • 5.4 Reproductive cavity
  • 5.5 Skin
  • 5.6 Other sites

Chapter 6 Human Microbiome Market, By Application, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by application
  • 6.2 Therapeutics
  • 6.3 Diagnostics

Chapter 7 Human Microbiome Market, By Disease, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by disease
  • 7.2 Infectious diseases
  • 7.3 Gastrointestinal diseases
  • 7.4 Endocrine & metabolic diseases
  • 7.5 Cancer
  • 7.6 Cetral nervous system disorder
  • 7.7 Other diseases

Chapter 8 Human Microbiome Market, By Product, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by product
  • 8.2 Drugs
  • 8.3 Probiotics
  • 8.4 Prebiotics
  • 8.5 Diagnostic tests
  • 8.6 Other products

Chapter 9 Human Microbiome Market, By Region, 2018 - 2032 (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 MEA
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of MEA

Chapter 10 Company Profiles

  • 10.1 Seres Therapeutics
  • 10.2 Enterome
  • 10.3 Second Genome Inc.
  • 10.4 DuPont
  • 10.5 Synthetic Biologics, Inc.
  • 10.6 Synlogic
  • 10.7 Vedanta Biosciences, Inc.
  • 10.8 Metabiomics Corporation
  • 10.9 MICROBIOME THERAPEUTICS LLC
  • 10.10 4D pharma plc

Data Tables

  • TABLE 1 Market revenue, by site (2022)
  • TABLE 2 Market revenue, by application (2022)
  • TABLE 3 Market share, by disease (2022)
  • TABLE 4 Market share, by product (2022
  • TABLE 5 Market share, by region (2022)
  • TABLE 6 Global human microbiome market size, by region, 2018 - 2022 (USD Million)
  • TABLE 7 Global human microbiome market size, by region, 2023 - 2032 (USD Million)
  • TABLE 8 Global human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 9 Global human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 10 Global human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 11 Global human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 12 Global human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 13 Global human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 14 Global human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 15 Global human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 16 Industry impact forces
  • TABLE 17 Digestive tract market size, 2018 - 2022 (USD Million)
  • TABLE 18 Digestive tract market size, 2023 - 2032 (USD Million)
  • TABLE 19 Lung market size, 2018 - 2022 (USD Million)
  • TABLE 20 Lung market size, 2023 - 2032 (USD Million)
  • TABLE 21 Reproductive cavity market size, 2018 - 2022 (USD Million)
  • TABLE 22 Reproductive cavity market size, 2023 - 2032 (USD Million)
  • TABLE 23 Skin market size, 2018 - 2022 (USD Million)
  • TABLE 24 Skin market size, 2023 - 2032 (USD Million)
  • TABLE 25 Other sites market size, 2018 - 2022 (USD Million)
  • TABLE 26 Other sites market size, 2023 - 2032 (USD Million)
  • TABLE 27 Therapeutics market size, 2018 - 2022 (USD Million)
  • TABLE 28 Therapeutics market size, 2023 - 2032 (USD Million)
  • TABLE 29 Diagnostics market size, 2018 - 2022 (USD Million)
  • TABLE 30 Diagnostics market size, 2023 - 2032 (USD Million)
  • TABLE 31 Infectious diseases market size, 2018 - 2022 (USD Million)
  • TABLE 32 Infectious diseases market size, 2023 - 2032 (USD Million)
  • TABLE 33 Gastrointestinal diseases market size, 2018 - 2022 (USD Million)
  • TABLE 34 Gastrointestinal diseases market size, 2023 - 2032 (USD Million)
  • TABLE 35 Endocrine & metabolic diseases market size, 2018 - 2022 (USD Million)
  • TABLE 36 Endocrine & metabolic diseases market size, 2023 - 2032 (USD Million)
  • TABLE 37 Cancer market size, 2018 - 2022 (USD Million)
  • TABLE 38 Cancer market size, 2023 - 2032 (USD Million)
  • TABLE 39 Central nervous system disorder market size, 2018 - 2022 (USD Million)
  • TABLE 40 Central nervous system disorder market size, 2023 - 2032 (USD Million)
  • TABLE 41 Other diseases market size, 2018 - 2022 (USD Million)
  • TABLE 42 Other diseases market size, 2023 - 2032 (USD Million)
  • TABLE 43 Drug market size, 2018 - 2022 (USD Million)
  • TABLE 44 Drug market size, 2023 - 2032 (USD Million)
  • TABLE 45 Probiotics market size, 2018 - 2022 (USD Million)
  • TABLE 46 Probiotics market size, 2023 - 2032 (USD Million)
  • TABLE 47 Prebiotics market size, 2018 - 2022 (USD Million)
  • TABLE 48 Prebiotics market size, 2023 - 2032 (USD Million)
  • TABLE 49 Diagnostic tests market size, 2018 - 2022 (USD Million)
  • TABLE 50 Diagnostic tests market size, 2023 - 2032 (USD Million)
  • TABLE 51 Other products market size, 2018 - 2022 (USD Million)
  • TABLE 52 Other products market size, 2023 - 2032 (USD Million)
  • TABLE 53 North America human microbiome market size, by country, 2018 - 2022 (USD Million)
  • TABLE 54 North America human microbiome market size, by country, 2023 - 2032 (USD Million)
  • TABLE 55 North America human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 56 North America human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 57 North America human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 58 North America human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 59 North America human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 60 North America human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 61 North America human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 62 North America human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 63 U.S. human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 64 U.S. human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 65 U.S. human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 66 U.S. human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 67 U.S. human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 68 U.S. human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 69 U.S. human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 70 U.S. human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 71 Canada human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 72 Canada human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 73 Canada human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 74 Canada human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 75 Canada human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 76 Canada human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 77 Canada human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 78 Canada human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 79 Europe human microbiome market size, by country, 2018 - 2022 (USD Million)
  • TABLE 80 Europe human microbiome market size, by country, 2023 - 2032 (USD Million)
  • TABLE 81 Europe human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 82 Europe human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 83 Europe human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 84 Europe human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 85 Europe human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 86 Europe human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 87 Europe human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 88 Europe human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 89 Germany human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 90 Germany human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 91 Germany human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 92 Germany human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 93 Germany human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 94 Germany human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 95 Germany human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 96 Germany human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 97 UK human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 98 UK human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 99 UK human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 100 UK human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 101 UK human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 102 UK human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 103 UK human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 104 UK human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 105 France human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 106 France human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 107 France human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 108 France human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 109 France human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 110 France human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 111 France human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 112 France human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 113 Spain human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 114 Spain human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 115 Spain human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 116 Spain human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 117 Spain human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 118 Spain human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 119 Spain human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 120 Spain human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 121 Italy human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 122 Italy human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 123 Italy human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 124 Italy human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 125 Italy human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 126 Italy human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 127 Italy human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 128 Italy human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 129 Rest of Europe human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 130 Rest of Europe human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 131 Rest of Europe human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 132 Rest of Europe human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 133 Rest of Europe human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 134 Rest of Europe human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 135 Rest of Europe human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 136 Rest of Europe human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 137 Asia Pacific human microbiome market size, by country, 2018 - 2022 (USD Million)
  • TABLE 138 Asia Pacific human microbiome market size, by country, 2023 - 2032 (USD Million)
  • TABLE 139 Asia Pacific human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 140 Asia Pacific human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 141 Asia Pacific human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 142 Asia Pacific human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 143 Asia Pacific human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 144 Asia Pacific human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 145 Asia Pacific human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 146 Asia Pacific human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 147 Japan human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 148 Japan human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 149 Japan human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 150 Japan human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 151 Japan human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 152 Japan human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 153 Japan human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 154 Japan human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 155 China human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 156 China human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 157 China human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 158 China human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 159 China human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 160 China human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 161 China human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 162 China human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 163 India human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 164 India human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 165 India human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 166 India human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 167 India human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 168 India human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 169 India human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 170 India human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 171 Australia human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 172 Australia human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 173 Australia human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 174 Australia human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 175 Australia human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 176 Australia human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 177 Australia human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 178 Australia human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 179 Rest of Asia Pacific human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 180 Rest of Asia Pacific human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 181 Rest of Asia Pacific human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 182 Rest of Asia Pacific human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 183 Rest of Asia Pacific human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 184 Rest of Asia Pacific human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 185 Rest of Asia Pacific human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 186 Rest of Asia Pacific human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 187 Latin America human microbiome market size, by country, 2018 - 2022 (USD Million)
  • TABLE 188 Latin America human microbiome market size, by country, 2023 - 2032 (USD Million)
  • TABLE 189 Latin America human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 190 Latin America human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 191 Latin America human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 192 Latin America human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 193 Latin America human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 194 Latin America human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 195 Latin America human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 196 Latin America human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 197 Brazil human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 198 Brazil human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 199 Brazil human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 200 Brazil human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 201 Brazil human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 202 Brazil human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 203 Brazil human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 204 Brazil human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 205 Mexico human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 206 Mexico human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 207 Mexico human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 208 Mexico human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 209 Mexico human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 210 Mexico human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 211 Mexico human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 212 Mexico human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 213 Rest of Latin America human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 214 Rest of Latin America human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 215 Rest of Latin America human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 216 Rest of Latin America human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 217 Rest of Latin America human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 218 Rest of Latin America human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 219 Rest of Latin America human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 220 Rest of Latin America human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 221 Middle East & Africa human microbiome market size, by country, 2018 - 2022 (USD Million)
  • TABLE 222 Middle East & Africa human microbiome market size, by country, 2023 - 2032 (USD Million)
  • TABLE 223 Middle East & Africa human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 224 Middle East & Africa human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 225 Middle East & Africa human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 226 Middle East & Africa human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 227 Middle East & Africa human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 228 Middle East & Africa human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 229 Middle East & Africa human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 230 Middle East & Africa human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 231 Saudi Arabia human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 232 Saudi Arabia human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 233 Saudi Arabia human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 234 Saudi Arabia human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 235 Saudi Arabia human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 236 Saudi Arabia human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 237 Saudi Arabia human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 238 Saudi Arabia human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 239 South Africa human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 240 South Africa human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 241 South Africa human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 242 South Africa human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 243 South Africa human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 244 South Africa human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 245 South Africa human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 246 South Africa human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 247 Rest of Middle East & Africa human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 248 Rest of Middle East & Africa human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 249 Rest of Middle East & Africa human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 250 Rest of Middle East & Africa human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 251 Rest of Middle East & Africa human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 252 Rest of Middle East & Africa human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 253 Rest of Middle East & Africa human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 254 Rest of Middle East & Africa human microbiome market size, by product, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Market estimation and forecast methodology
  • FIG 3 Market forecasting methodology
  • FIG 4 Breakdown of primary participants
  • FIG 5 Human microbiome industry 360 degree synopsis, 2018 - 2032
  • FIG 6 Growth potential analysis, by site
  • FIG 7 Growth potential analysis, by application
  • FIG 8 Growth potential analysis, by disease
  • FIG 9 Growth potential analysis, by product
  • FIG 10 Porter's analysis
  • FIG 11 PESTEL analysis
  • FIG 12 Company matrix analysis, 2022
  • FIG 13 Competitive analysis of major market players, 2022
  • FIG 14 Competitive positioning matrix
  • FIG 15 Strategic dashboard, 2022